– Elizabeth Tarka, M.D. appointed Chief Medical Officer – A. Brian Davis named Chief Financial Officer WAYNE, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics, a clinical‑stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced that it has appointed Elizabeth Tarka, M.D. as Chief Medical Officer and A. Brian Davis as Chief […]
Financial
CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer. In this role Charles will lead the scientific and clinical development of the CorVista System for commercialization. “We are […]
Foldax Appoints Scott Huennekens to Board of Directors
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced the appointment of medical device veteran Scott Huennekens as an independent member of the company’s board of directors. Huennekens possesses more than 30 years of experience in the medical device industry, leading high-profile companies through IPOs and acquisitions, and serving on the board […]
Getinge appoints Patricia Fitch as President North America Region
GOTHENBURG, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints Patricia Fitch as President North America Region. Patricia succeeds Eric Honroth who has been appointed President Life Science at Getinge. Patricia Fitch joined Getinge in March 2021 as Vice President US Sales covering the Acute Care Therapies division. Patricia has more than 30 years of medical device experience, having held leadership […]
Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
GREENVILLE, S.C.–(BUSINESS WIRE)–Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board. The Board is comprised of leading industry and university experts in cardiovascular research and clinical development. Former […]
Getinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as President Life Science
GETINGE, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints new Presidents for two business areas and members of the Executive team. Elin Frostehav is appointed President Acute Care Therapies and Eric Honroth President Life Science starting April 1, 2022. Elin Frostehav has been appointed President Acute Care Therapies and member of the Getinge Executive team. […]
CinCor Pharma Appoints June Lee to Its Board of Directors
BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member June Lee, M.D. to the company’s Board of Directors. Dr. Lee brings decades of leadership experience in the biotechnology and pharmaceutical industry and has served in numerous executive and board […]
AliveCor Announces Strategic Additions to Executive Team
MOUNTAIN VIEW, Calif., Jan. 11, 2022 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the addition of four new leaders to the company’s executive team: Vincent Balsamo as Executive Vice President of Worldwide Sales, Dr. Archana Dubey as Chief Clinical Officer, Dr. Ben Green as Senior Vice President of Services, and Jessica Weinstein as Senior […]
Humanitarian and Philanthropic Leader Vivian G. Bass Elected President of Save a Child’s Heart
ROCKVILLE, Md., Jan. 11, 2022 /PRNewswire/ — Save a Child’s Heart (SACH) Board of Directors of the US branch elected Vivian G. Bass of Bethesda, Maryland to serve as President effective January 1, 2022. “Vivian is an outstanding visionary and legendary leader who is highly respected and admired by individuals of all ages, cultures, religions, and socioeconomic statuses,” […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2021 it granted stock options to purchase an aggregate of 90,000 shares of common stock to 9 new employees, whose employment commenced in December 2021, as a material inducement to […]



